Epidemiological evolution of influenza, IACRS and COVID-19

The National Agency for Public Health continues the surveillance of respiratory infections and the monitoring of the circulation of influenza viruses and SARS-CoV-2 at territorial and national level. In the period 06.10.2025-12.10.2025 (week 41/2025), 1725 cases of IACRS were registered, most of them in children, decreasing by 1.3% compared to the previous week.

During the nominal period three cases of seasonal flu were registered (2-mun. Chisinau, 1-Anenii Us).

In the ANSP laboratories, during this period, 27 samples were investigated for the presence of influenza, non-influenza and SARS-CoV-2 viruses.

At the same time, 49 cases of COVID-19 were registered, down by 20% compared to the previous week. Among children aged 0-14 years, 16 cases were reported.

For the specific prophylaxis of seasonal flu for the professional contingent and people at increased risk of illness in the 2025/2026 flu season, the Republic of Moldova purchased in September 2025 a batch of 240 thousand doses of Influvac Tetra flu vaccine, with a dose of 0.5 ml in a syringe prefilled. The composition of the vaccine fully complies with the recommendations of the World Health Organization.

ANSP urges the population to simultaneously vaccinate against the seasonal flu and the infection caused by the SARS-CoV-2 virus. Seroprotection is generally achieved 2 to 3 weeks after vaccination. The duration of post-vaccination immunity varies between 6 and 12 months.

ANSP reiterates that the benefits of vaccination are significant. But in addition to vaccination, it is essential that the population adopt personal hygiene measures such as washing hands with soap and water, using tissues when sneezing or coughing, and maintaining a healthy lifestyle that includes a diet rich in vegetables and fruits, adequate rest, and regular exercise. These measures, combined with vaccination, offer the best protection against influenza and other respiratory infections.